Yongin, South Korea

Soo Jin Choi

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 5.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Yongin-si, KR (2015)
  • Seoul, KR (2009 - 2016)
  • Yongin, KR (2015 - 2016)

Company Filing History:


Years Active: 2009-2025

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Inventor Soo Jin Choi from Yongin, South Korea**

Introduction

Soo Jin Choi is an esteemed inventor based in Yongin, South Korea, recognized for her innovative contributions to pharmaceutical science. With a commendable portfolio that includes eight patents, Choi is making significant strides in the treatment of inflammatory diseases and nerve injuries through her groundbreaking research on mesenchymal stem cells.

Latest Patents

Choi’s recent patents exemplify her commitment to advancing medical technology. One notable patent is for a pharmaceutical composition that utilizes mesenchymal stem cells expressing HLA-A2 as an effective ingredient for the prevention or treatment of inflammatory diseases. This composition inhibits the secretion of the inflammatory cytokine TNF-a while enhancing the expression of anti-inflammatory markers such as CD163 and Arg-1, positioning it as a valuable option for managing inflammation.

Another significant patent involves the use of umbilical cord blood-derived mesenchymal stem cells aimed at treating nerve injuries. This innovative composition promotes the differentiation and proliferation of neural precursor and stem cells into functional neural cells, showcasing its effectiveness in addressing nerve injury diseases.

Career Highlights

Throughout her career, Soo Jin Choi has made impactful contributions while working with notable pharmaceutical companies, including Daewoong Pharmaceutical Co., Ltd. and Medipost Co., Ltd. Her expertise in stem cell research and pharmaceutical compositions has established her as a leading figure in her field, contributing to advancements that improve patient care and therapeutic outcomes.

Collaborations

Choi's research initiatives have also benefited from collaboration with esteemed colleagues such as Byung Goo Lee and Wonil Oh. These partnerships have fostered an environment of innovation, enabling the cross-pollination of ideas that drive progress in the realm of cellular therapies.

Conclusion

Soo Jin Choi stands out as a pioneering inventor dedicated to harnessing the potential of mesenchymal stem cells in medical treatments. Her innovative patents and collaborative efforts not only reflect her commitment to scientific advancement but also offer hope for improving the lives of individuals suffering from inflammatory diseases and nerve injuries. As she continues her work, the impact of her inventions is likely to resonate within the pharmaceutical landscape for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…